In the current market session, Abbott Laboratories Inc. (NYSE:ABT) stock price is at $116.19, after a 0.68% decrease. However, over the past month, the company's stock increased by 2.51%, and in the past year, by 24.17%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session.
Abbott Laboratories P/E Ratio Analysis in Relation to Industry Peers
Abbott Laboratories has a lower P/E than the aggregate P/E of 265.82 of the Health Care Equipment & Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
